Demographic data Demographic data Demographic data Demographic data Demographic data Demographic data Demographic data Comorbidities Comorbidities Comorbidities Comorbidities Comorbidities Comorbidities Asthma treatment Asthma treatment Asthma treatment Asthma treatment Asthma treatment Asthma treatment
IRSA center id. Region Province Pt. ID Sex Age BMI Smoking (active) Hypertension Nasal polyps Bronchiectasis GERD Comorbidities (n.) Treatment Add-on biologic drug COVID-19 severity COVID-19 severity COVID-19 severity ICU admission
25 E-R R. Emilia 1 F 48 32.1 No No No No No 1 (Obesity) ICS+LABA Omalizumab Home care Home care Home care -
40 Lombardy Bergamo 2 F 65 24.5 No Yes No No No 1 ICS+LABA+OCS Omalizumab Hospitalized Hospitalized Hospitalized No
46 Lombardy Milan 3 F 40 29 No No Yes Yes No 2 ICS+LABA+LAMA Mepolizumab Home care Home care Home care -
102 Lombardy Cremona 4 F 51 25.2 No No Yes Yes No 2 ICS+LABA+LAMA Omalizumab Home care Home care Home care -
114 Lombardy Brescia 5 F 57 22.3 No Yes Yes Yes No 3 ICS+LABA+LAMA Mepolizumab Hospitalized Hospitalized Hospitalized No
114 Lombardy Brescia 6 M 65 26.1 No No No No Yes 1 ICS+LABA+LAMA Mepolizumab Home care Home care Home care -
114 Lombardy Brescia 7 F 56 17.9 No No Yes No No 1 ICS+LABA Mepolizumab Home care Home care Home care -
Average - - - - 54.6 25.3 - - - - - 1.6 - - - - - -
SD - - - - 8.4 4.2 - - - - - 0.7 - - - - - -